XS
XR Securities’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 98 |
|
|
2024
Q3 | – | Sell |
-5,872
| Closed | -$544K | – | 131 |
|
|
2024
Q2 | $544K | Buy |
5,872
+220
| +4% | +$20.4K | 0.1% | 30 |
|
|
2024
Q1 | $536K | Buy |
5,652
+372
| +7% | +$35.3K | 0.02% | 38 |
|
|
2023
Q4 | $471K | Buy |
5,280
+2,382
| +82% | +$213K | 0.02% | 43 |
|
|
2023
Q3 | $212K | Buy |
+2,898
| New | +$212K | 0.02% | 55 |
|
|
2023
Q2 | – | Sell |
-5,135
| Closed | -$391K | – | 243 |
|
|
2023
Q1 | $391K | Sell |
5,135
-3,777
| -42% | -$288K | 0.01% | 45 |
|
|
2022
Q4 | $740K | Sell |
8,912
-19,099
| -68% | -$1.59M | 0.07% | 29 |
|
|
2022
Q3 | $2.22M | Buy |
28,011
+8,550
| +44% | +$678K | 1.21% | 9 |
|
|
2022
Q2 | $1.45M | Buy |
+19,461
| New | +$1.45M | 0.48% | 19 |
|
|
2022
Q1 | – | Sell |
-8,647
| Closed | -$968K | – | 305 |
|
|
2021
Q4 | $968K | Buy |
8,647
+3,778
| +78% | +$423K | 0.09% | 29 |
|
|
2021
Q3 | $612K | Sell |
4,869
-5,064
| -51% | -$637K | 0.28% | 41 |
|
|
2021
Q2 | $1.35M | Sell |
9,933
-5,783
| -37% | -$783K | 0.59% | 18 |
|
|
2021
Q1 | $2.13M | Buy |
+15,716
| New | +$2.13M | 0.12% | 12 |
|
|
2020
Q2 | – | Sell |
-3,396
| Closed | -$263K | – | 242 |
|
|
2020
Q1 | $263K | Buy |
+3,396
| New | +$263K | 0.02% | 74 |
|
|
2019
Q4 | – | Sell |
-3,057
| Closed | -$233K | – | 201 |
|
|
2019
Q3 | $233K | Buy |
+3,057
| New | +$233K | 0.03% | 82 |
|
|
2019
Q2 | – | Sell |
-6,074
| Closed | -$550K | – | 243 |
|
|
2019
Q1 | $550K | Sell |
6,074
-608
| -9% | -$55.1K | 0.07% | 64 |
|
|
2018
Q4 | $479K | Buy |
+6,682
| New | +$479K | 0.21% | 47 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 263 |
|